Higher immunoglobulin A nephropathy recurrence in related‐donor kidney transplants: The Japan Academic Consortium of Kidney Transplantation study

2019 ◽  
Vol 26 (9) ◽  
pp. 903-909
Author(s):  
Masayoshi Okumi ◽  
Daigo Okada ◽  
Kohei Unagami ◽  
Yoichi Kakuta ◽  
Junpei Iizuka ◽  
...  
2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Gaia Peluso ◽  
Silvia Campanile ◽  
Alessandro Scotti ◽  
Vincenzo Tammaro ◽  
Akbar Jamshidi ◽  
...  

Introduction. SARS-CoV-2 is a virus that causes a potentially deadly syndrome that affects especially the respiratory tract. Kidney-transplanted patients are immunosuppressed and more susceptible to viral infections. We have examined our transplantation activity to explore the future role of kidney transplantation from deceased and living donors in COVID-19 era. Patients and Methods. The activity of our transplant center of Naples (one of the two transplant centers in Campania, South Italy) continued during the COVID-19 pandemic. We have analysed the kidney transplants carried out between March 9 and June 9, 2020, comparing these data with the numbers of procedures performed in the two previous years. Moreover, we have considered the possibility of performing living donor transplants during a worldwide pandemic. Results. From March 9, 2020, when the Italian lockdown begun, till June 9, 2020, five kidney transplants have been performed at our transplant center in Naples, all from deceased donors. The donors and the recipients have been screened for COVID-19 infection, and the patients, all asymptomatic, followed strict preventive measures and were fully informed about the risks of surgery and immunosuppression during a pandemic. All the transplanted patients remained COVID negative during the follow-up. The number of transplants performed has been constant compared to the same months of 2018 and 2019. In agreement with the patients, we decided to postpone living donor transplants to a period of greater control of the SARS-CoV-2 spread in Italy. Conclusion. Deceased donor kidney transplantation should continue, especially in a region with moderate risk, like Campania, with a more careful selection of donors and recipients, preferring standard donors and recipients without severe comorbidities. Living donor transplantation program, instead, should be postponed to a period of greater control of the SARS-CoV-2 spread, as it is an elective surgery and its delay does not determine additional risks for patients.


2011 ◽  
Vol 40 (10) ◽  
pp. 458-461
Author(s):  
Fangfang Sun ◽  
Yan Wang ◽  
Wanzhen Xu ◽  
Ye Tian ◽  
Lei Zhang ◽  
...  

2017 ◽  
Vol 3 (1) ◽  
Author(s):  
Hiroshi Nihei ◽  
Ken Sakai ◽  
Seiichiro Shishido ◽  
Kazutoshi Sibuya ◽  
Hideo Edamatsu ◽  
...  

BMC Surgery ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Utku Ozgen ◽  
Murat Ozban ◽  
Onur Birsen ◽  
Sevda Yilmaz ◽  
Belda Dursun ◽  
...  

Abstract Background Kidney transplantation is the most preferred type of renal displacement therapy for end stage renal disease (ESRD) patients. More patients developed ESRD. The most important source is the donations from unrelated spouses. In this study, we aimed to compare the transplantation data obtained from the spouses of the patients with the transplantation data obtained from other relatives. Methods The data including 167 living kidney transplantations performed between January 2006 and December 2019 were retrospectively collected. The patients were divided into two groups; spousal donor group (n: 53) and living-related donor group (n: 114). Results There was no significant difference in delayed graft function in both groups. There were no patients with acute rejection proven by biopsy or considered biochemically in the spousal donor group. With regard to 3-year results in the living-related donor group the patient survival rate was 100%, while it was 98.2% in terms of graft survival. Conclusions In conclusion, similar patient and graft survival rates between spousal donor kidney transplantation and living-related kidney transplantation has made spousal donor kidney transplantation, with possible problems in terms of tissue compatibility, an acceptable alternative to donor supply.


2014 ◽  
Vol 29 (1) ◽  
pp. 209-218 ◽  
Author(s):  
Priya S. Verghese ◽  
Ty B. Dunn ◽  
Srinath Chinnakotla ◽  
Kristin J. Gillingham ◽  
Arthur J. Matas ◽  
...  

2016 ◽  
Vol 21 ◽  
pp. 587-595 ◽  
Author(s):  
Clotilde Fuentes-Orozco ◽  
Salvador González-Mercado ◽  
Joel Mario Sandoval-Sandoval ◽  
Carlos Valdespino-Mejía ◽  
Eduardo González-González ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document